nach oben

Current Cardiology Reports

Erschienen in:

04.08.2023 | Women and Cardiovascular Health (N Goldberg and S Lewis, Section Editors)

Cardio-Obstetrics: A Focused Review

verfasst von: Amrit Misra, Maria Pabon Porras, Aardra Rajendran, Johanna Contreras, Nandita S. Scott

Erschienen in: Current Cardiology Reports | Ausgabe 9/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

Cardiovascular disease is the leading cause of maternal mortality in the USA. All cardiovascular care providers should have a foundational knowledge on the management of pregnant individuals with heart disease. This focused review touches on several key cardio-obstetric themes.

Recent Findings

Many individuals with cardiovascular disease can safely undergo pregnancy, but should have counseling preconception to optimize cardiac status. There are several cardiovascular conditions that are high risk for maternal mortality and morbidity. These individuals should be adequately counseled preconception and offered reliable birth control.

Summary

The approach to a high-risk pregnant patient with cardiac disease is best managed by a multidisciplinary team to address potential maternal and fetal complications. Identification of at risk individuals can be estimated preconception with several risk scores. The development of risk scores to stratify and identify those at elevated risk during pregnancy is an area of continued research and development.

Scott K, Gregory EF, Burris HH. Addressing maternal mortality in the US-a pediatrics responsibility. JAMA. 2023. https://doi.org/10.1001/jama.2023.6234.CrossRefPubMed

Hoyert D. Maternal mortality rates in the United States, 2021. NCHS Health E-Stats 2023. https://doi.org/10.15620/cdc:124678.

Brigance C, Lucas R, Jones E, et al. Nowhere to go: maternity care deserts across the U.S. (Report No. 3). https://www.marchofdimes.org/research/maternity-care-deserts-report.aspx. Accessed 28 May 2023.

Stevenson AJ, Root L, Menken J. The maternal mortality consequences of losing abortion access. 2022. https://doi.org/10.31235/osf.io/7g29k.

Yucel E, DeFaria YD. Pregnancy in women with congenital heart disease. Curr Treat Options Cardiovasc Med. 2017;19(9):73. https://doi.org/10.1007/s11936-017-0572-0.CrossRefPubMed

Sanghavi M, Rutherford JD. Cardiovascular physiology of pregnancy. Circulation. 2014;130(12):1003–8. https://doi.org/10.1161/CIRCULATIONAHA.114.009029.CrossRefPubMed

Hoes MF, Arany Z, Bauersachs J, et al. Pathophysiology and risk factors of peripartum cardiomyopathy. Nat Rev Cardiol. 2022;19(8):555–65. https://doi.org/10.1038/s41569-021-00664-8.CrossRefPubMed

Arany Z, Elkayam U. Peripartum cardiomyopathy. Circulation. 2016;133(14):1397–409. https://doi.org/10.1161/CIRCULATIONAHA.115.020491.CrossRefPubMed

Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, et al. 2018 ESC guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J. 2018;39(34):3165–241. https://doi.org/10.1093/eurheartj/ehy340.CrossRefPubMed

10.

Mehta LS, Warnes CA, Bradley E, et al. Cardiovascular considerations in caring for pregnant patients: a scientific statement from the American Heart Association. Circulation. 2020;141(23):e884–903. https://doi.org/10.1161/CIR.0000000000000772.CrossRefPubMed

11.

Silversides CK, Grewal J, Mason J, et al. Pregnancy outcomes in women with heart disease: the CARPREG II study. J Am Coll Cardiol. 2018;71(21):2419–30. https://doi.org/10.1016/j.jacc.2018.02.076.CrossRefPubMed

12.

Drenthen W, Boersma E, Balci A, et al. Predictors of pregnancy complications in women with congenital heart disease. Eur Heart J. 2010;31(17):2124–32. https://doi.org/10.1093/eurheartj/ehq200.CrossRefPubMed

13.

Denayer N, Troost E, Santens B, et al. Comparison of risk stratification models for pregnancy in congenital heart disease. Int J Cardiol. 2021;323:54–60. https://doi.org/10.1016/j.ijcard.2020.09.033.CrossRefPubMed

14.

van Hagen IM, Boersma E, Johnson MR, et al. Global cardiac risk assessment in the registry of pregnancy and cardiac disease: results of a registry from the European Society of Cardiology. Eur J Heart Fail. 2016;18(5):523–33. https://doi.org/10.1002/ejhf.501.CrossRefPubMed

15.

Bredy C, Deville F, Huguet H, et al. Which risk score best predicts cardiovascular outcome in pregnant women with congenital heart disease? Eur Heart J Qual Care Clin Outcomes. 2023;9(2):177–83. https://doi.org/10.1093/ehjqcco/qcac019.CrossRefPubMed

16.

• Hameed AB, Tarsa M, Graves CR, et al. Cardiovascular risk assessment as a quality measure in the pregnancy and postpartum period. JACC Adv. 2023;2(1):100176. https://doi.org/10.1016/j.jacadv.2022.100176. Screening tool to identify pregnant and post partum individuals that may be at higher risk for cardiovascular disease. Important contribution as helps to identify those individuals without known cardiovascular disease who may warrant further cardiac evaluation.

17.

Scott N, Sarma A, Choi E. Bridging the gap in maternal cardiovascular risk: identifying patients at elevated risk. JACC Adv. 2023. https://doi.org/10.1016/j.jacadv.2022.100177.CrossRef

18.

Savu O, Jurcut R, Giusca S, et al. Morphological and functional adaptation of the maternal heart during pregnancy. Circ Cardiovasc Imaging. 2012;5(3):289–97. https://doi.org/10.1161/CIRCIMAGING.111.970012.CrossRefPubMed

19.

Liu S, Elkayam U, Naqvi TZ. Echocardiography in pregnancy: Part 1. Curr Cardiol Rep. 2016;18(9):92. https://doi.org/10.1007/s11886-016-0760-7.CrossRefPubMed

20.

Curtis SL, Belham M, Bennett S, et al. Transthoracic echocardiographic assessment of the heart in pregnancy-a position statement on behalf of the British Society of Echocardiography and the United Kingdom Maternal Cardiology Society. Echo Res Pract. 2023;10(1):7. https://doi.org/10.1186/s44156-023-00019-8.CrossRefPubMedPubMedCentral

21.

Afari HA, Davis EF, Sarma AA. Echocardiography for the pregnant heart. Curr Treat Options Cardiovasc Med. 2021;23(8):55. https://doi.org/10.1007/s11936-021-00930-5.CrossRefPubMedPubMedCentral

22.

Melchiorre K, Sharma R, Khalil A, Thilaganathan B. Maternal cardiovascular function in normal pregnancy: evidence of maladaptation to chronic volume overload. Hypertension. 2016;67(4):754–62. https://doi.org/10.1161/HYPERTENSIONAHA.115.06667.CrossRefPubMed

23.

Sadaniantz A, Kocheril AG, Emaus SP, Garber CE, Parisi AF. cardiovascular changes in pregnancy evaluated by two-dimensional and doppler echocardiography. J Am Soc Echocardiogr. 1992;5(3):253–8. https://doi.org/10.1016/s0894-7317(14)80345-3.CrossRefPubMed

24.

Colletti PM, Lee KH, Elkayam U. Cardiovascular imaging of the pregnant patient. AJR Am J Roentgenol. 2013;200(3):515–21. https://doi.org/10.2214/AJR.12.9864.CrossRefPubMed

25.

Tamirisa KP, Elkayam U, Briller JE, et al. Arrhythmias in pregnancy. JACC Clin Electrophysiol. 2022;8(1):120–35. https://doi.org/10.1016/j.jacep.2021.10.004.CrossRefPubMed

26.

Halpern DG, Weinberg CR, Pinnelas R, Mehta-Lee S, Economy KE, Valente AM. Use of medication for cardiovascular disease during pregnancy: JACC state-of-the-art review. J Am Coll Cardiol. 2019;73(4):457–76. https://doi.org/10.1016/j.jacc.2018.10.075.CrossRefPubMed

27.

Pinheiro EA, Stika CS. Drugs in pregnancy: pharmacologic and physiologic changes that affect clinical care. Semin Perinatol. 2020;44(3):151221. https://doi.org/10.1016/j.semperi.2020.151221.CrossRefPubMedPubMedCentral

28.

Kaye AB, Bhakta A, Moseley AD, et al. Review of cardiovascular drugs in pregnancy. J Womens Health (Larchmt). 2019;28(5):686–97. https://doi.org/10.1089/jwh.2018.7145.CrossRefPubMed

29.

Katsi V, Papakonstantinou IP, Papazachou O, Makris T, Tsioufis K. Beta-blockers in pregnancy: clinical update. Curr Hypertens Rep. 2023;25(2):13–24. https://doi.org/10.1007/s11906-023-01234-8.CrossRefPubMed

30.

Kinsella SM, Carvalho B, Dyer RA, et al. International consensus statement on the management of hypotension with vasopressors during caesarean section under spinal anaesthesia. Anaesthesia. 2018;73(1):71–92. https://doi.org/10.1111/anae.14080.CrossRefPubMed

31.

Riester A, Reincke M. Progress in primary aldosteronism: mineralocorticoid receptor antagonists and management of primary aldosteronism in pregnancy. Eur J Endocrinol. 2015;172(1):R23-30. https://doi.org/10.1530/EJE-14-0444.CrossRefPubMed

32.

Cooper WO, Hernandez-Diaz S, Arbogast PG, et al. Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med. 2006;354(23):2443–51. https://doi.org/10.1056/NEJMoa055202.CrossRefPubMed

33.

• Lindley KJ, Bairey Merz CN, Asgar AW, et al. Management of women with congenital or inherited cardiovascular disease from pre-conception through pregnancy and postpartum: JACC Focus Seminar 2/5. J Am Coll Cardiol. 2021;77(14):1778–98. https://doi.org/10.1016/j.jacc.2021.02.026. Multifaceted review on the management of pregnant individuals with cardiovascular disease. Notable for the comprehensive overview of the field.CrossRefPubMedPubMedCentral

34.

Ruys TP, Roos-Hesselink JW, Pijuan-Domenech A, et al. Is a planned caesarean section in women with cardiac disease beneficial? Heart. 2015;101(7):530–6. https://doi.org/10.1136/heartjnl-2014-306497.CrossRefPubMed

35.

Angeli L, Fieni S, Dall’Asta A, et al. Mode of delivery and peripartum outcome in women with heart disease according to the ESC guidelines: an Italian multicenter study. J Matern Fetal Neonatal Med. 2023;36(1):2184221. https://doi.org/10.1080/14767058.2023.2184221.CrossRefPubMed

36.

Gavin NR, Federspiel JJ, Boyer T, et al. Mode of delivery among women with maternal cardiac disease. J Perinatol. 2023. https://doi.org/10.1038/s41372-023-01625-4.CrossRefPubMed

37.

Magun E, DeFilippis EM, Noble S, et al. Cardiovascular care for pregnant women with cardiovascular disease. J Am Coll Cardiol. 2020;76(18):2102–13. https://doi.org/10.1016/j.jacc.2020.08.071.CrossRefPubMed

38.

Siu SC, Sermer M, Colman JM, et al. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation. 2001;104(5):515–21. https://doi.org/10.1161/hc3001.093437.CrossRefPubMed

39.

Orwat S, Diller GP, van Hagen IM, et al. Risk of pregnancy in moderate and severe aortic stenosis: from the multinational ROPAC registry. J Am Coll Cardiol. 2016;68(16):1727–37. https://doi.org/10.1016/j.jacc.2016.07.750.CrossRefPubMed

40.

Lewey J, Andrade L, Levine LD. Valvular heart disease in pregnancy. Cardiol Clin. 2021;39(1):151–61. https://doi.org/10.1016/j.ccl.2020.09.010.CrossRefPubMed

41.

Hodson R, Kirker E, Swanson J, Walsh C, Korngold EC, Ramelli S. Transcatheter aortic valve replacement during pregnancy. Circ Cardiovasc Interv. 2016. https://doi.org/10.1161/CIRCINTERVENTIONS.116.004006.CrossRefPubMed

42.

Drenthen W, Pieper PG, Roos-Hesselink JW, et al. Pregnancy and delivery in women after Fontan palliation. Heart. 2006;92(9):1290–4. https://doi.org/10.1136/hrt.2005.085407.CrossRefPubMedPubMedCentral

43.

Garcia Ropero A, Baskar S, Roos Hesselink JW, et al. Pregnancy in women with a Fontan circulation: a systematic review of the literature. Circ Cardiovasc Qual Outcomes. 2018;11(5):e004575. https://doi.org/10.1161/CIRCOUTCOMES.117.004575.CrossRefPubMed

44.

Eggleton EJ, McMurrugh KJ, Aiken CE. Maternal pregnancy outcomes in women with cardiomyopathy: a systematic review and meta-analysis. Am J Obstet Gynecol. 2022;227(4):582–92. https://doi.org/10.1016/j.ajog.2022.05.039.CrossRefPubMed

45.

Davis MB, Arany Z, McNamara DM, Goland S, Elkayam U. Peripartum cardiomyopathy: JACC state-of-the-art review. J Am Coll Cardiol. 2020;75(2):207–21. https://doi.org/10.1016/j.jacc.2019.11.014.CrossRefPubMed

46.

Elkayam U. Risk of subsequent pregnancy in women with a history of peripartum cardiomyopathy. J Am Coll Cardiol. 2014;64(15):1629–36. https://doi.org/10.1016/j.jacc.2014.07.961.CrossRefPubMed

47.

Braverman AC, Mittauer E, Harris KM, et al. Clinical features and outcomes of pregnancy-related acute aortic dissection. JAMA Cardiol. 2021;6(1):58–66. https://doi.org/10.1001/jamacardio.2020.4876.CrossRefPubMed

48.

Wanga S, Silversides C, Dore A, de Waard V, Mulder B. Pregnancy and thoracic aortic disease: managing the risks. Can J Cardiol. 2016;32(1):78–85. https://doi.org/10.1016/j.cjca.2015.09.003.CrossRefPubMed

49.

Roman MJ, Pugh NL, Hendershot TP, et al. Aortic complications associated with pregnancy in marfan syndrome: the NHLBI National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions (GenTAC). J Am Heart Assoc. 2016. https://doi.org/10.1161/JAHA.116.004052.CrossRefPubMedPubMedCentral

50.

Kamel H, Roman MJ, Pitcher A, Devereux RB. Pregnancy and the risk of aortic dissection or rupture: a cohort-crossover analysis. Circulation. 2016;134(7):527–33. https://doi.org/10.1161/CIRCULATIONAHA.116.021594.CrossRefPubMedPubMedCentral

51.

Nasiell J, Lindqvist PG. Aortic dissection in pregnancy: the incidence of a life-threatening disease. Eur J Obstet Gynecol Reprod Biol. 2010;149(1):120–1. https://doi.org/10.1016/j.ejogrb.2009.10.029.CrossRefPubMed

52.

Nienaber CA, Fattori R, Mehta RH, et al. Gender-related differences in acute aortic dissection. Circulation. 2004;109(24):3014–21. https://doi.org/10.1161/01.CIR.0000130644.78677.2C.CrossRef

53.

Campens L, Baris L, Scott NS, et al. Pregnancy outcome in thoracic aortic disease data from the Registry Of Pregnancy And Cardiac disease. Heart. 2021;107(21):1704–9. https://doi.org/10.1136/heartjnl-2020-318183.CrossRefPubMed

54.

Freaney PM, Harrington K, Molsberry R, et al. Temporal trends in adverse pregnancy outcomes in birthing individuals aged 15 to 44 years in the United States, 2007 to 2019. J Am Heart Assoc. 2022;11(11):e025050. https://doi.org/10.1161/JAHA.121.025050.CrossRefPubMedPubMedCentral

55.

Minhas AS, Ying W, Ogunwole SM, et al. The association of adverse pregnancy outcomes and cardiovascular disease: current knowledge and future directions. Curr Treat Options Cardiovasc Med. 2020. https://doi.org/10.1007/s11936-020-00862-6.CrossRefPubMedPubMedCentral

56.

Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019;74(10):e177–232. https://doi.org/10.1016/j.jacc.2019.03.010.CrossRefPubMedPubMedCentral

57.

Parikh NI, Gonzalez JM, Anderson CAM, et al. Adverse pregnancy outcomes and cardiovascular disease risk: unique opportunities for cardiovascular disease prevention in women: a scientific statement from the American Heart Association. Circulation. 2021;143(18):e902–16. https://doi.org/10.1161/CIR.0000000000000961.CrossRefPubMed

58.

Ford ND, Cox S, Ko JY, et al. Hypertensive disorders in pregnancy and mortality at delivery hospitalization - United States, 2017–2019. MMWR Morb Mortal Wkly Rep. 2022;71(17):585–91. https://doi.org/10.15585/mmwr.mm7117a1.CrossRefPubMedPubMedCentral

59.

Grandi SM, Filion KB, Yoon S, et al. Cardiovascular disease-related morbidity and mortality in women with a history of pregnancy complications. Circulation. 2019;139(8):1069–79. https://doi.org/10.1161/CIRCULATIONAHA.118.036748.CrossRefPubMed

60.

Groenhof TKJ, Zoet GA, Franx A, et al. Trajectory of cardiovascular risk factors after hypertensive disorders of pregnancy. Hypertension. 2019;73(1):171–8. https://doi.org/10.1161/HYPERTENSIONAHA.118.11726.CrossRefPubMed

61.

Gregory EC, Ely DM. Trends and characteristics in gestational diabetes: United States, 2016–2020. Natl Vital Stat Rep. 2022;71(3):1–15. https://www.ncbi.nlm.nih.gov/pubmed/35877134. Accessed 28 May 2023.

62.

Vounzoulaki E, Khunti K, Abner SC, Tan BK, Davies MJ, Gillies CL. Progression to type 2 diabetes in women with a known history of gestational diabetes: systematic review and meta-analysis. BMJ. 2020;369:m1361. https://doi.org/10.1136/bmj.m1361.CrossRefPubMedPubMedCentral

63.

Ngo AD, Roberts CL, Chen JS, Figtree G. Delivery of a small-for-gestational-age infant and risk of maternal cardiovascular disease–a population-based record linkage study. Heart Lung Circ. 2015;24(7):696–704. https://doi.org/10.1016/j.hlc.2015.01.004.CrossRefPubMed

64.

Wang YX, Minguez-Alarcon L, Gaskins AJ, et al. Pregnancy loss and risk of cardiovascular disease: the Nurses’ Health Study II. Eur Heart J. 2022;43(3):190–9. https://doi.org/10.1093/eurheartj/ehab737.CrossRefPubMed

65.

Sederholm Lawesson S, Swahn E, Pihlsgard M, et al. Association between history of adverse pregnancy outcomes and coronary artery disease assessed by coronary computed tomography angiography. JAMA. 2023;329(5):393–404. https://doi.org/10.1001/jama.2022.24093.CrossRefPubMedPubMedCentral

66.

Jowell AR, Sarma AA, Gulati M, et al. Interventions to mitigate risk of cardiovascular disease after adverse pregnancy outcomes: a review. JAMA Cardiol. 2022;7(3):346–55. https://doi.org/10.1001/jamacardio.2021.4391.CrossRefPubMedPubMedCentral

Titel: Cardio-Obstetrics: A Focused Review
verfasst von: Amrit Misra
Maria Pabon Porras
Aardra Rajendran
Johanna Contreras
Nandita S. Scott
Publikationsdatum: 04.08.2023
Verlag: Springer US
Erschienen in: Current Cardiology Reports / Ausgabe 9/2023
Print ISSN: 1523-3782
Elektronische ISSN: 1534-3170
DOI: https://doi.org/10.1007/s11886-023-01928-0

Neu im Fachgebiet Kardiologie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Cardio-Obstetrics: A Focused Review

Abstract

Purpose of Review

Recent Findings

Summary

Neu im Fachgebiet Kardiologie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

Update Kardiologie

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Purpose of Review

Recent Findings

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 9/2023

Efficacy of Bioactive Compounds in the Regulation of Metabolism and Pathophysiology in Cardiovascular Diseases

Venous Ethanol Ablation Approaches for Radiofrequency-Refractory Cardiac Arrhythmias

Update on Transcatheter Device Closure of Congenital Septal Defects

Addressing Cardiovascular Risk Across the Arc of a Woman’s Life: Sex-Specific Prevention and Treatment

Addressing PTSD in Implantable Cardioverter Defibrillator Patients: State-of-the-Art Management of ICD Shock and PTSD

Bempedoic Acid: A Contemporary Review of Its Pharmacology, Efficacy, and Safety Profile, Including Recent Data from the CLEAR Outcomes Clinical Trial

Neu im Fachgebiet Kardiologie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

Update Kardiologie